Decreased cortical excitability in Unverricht-Lundborg disease in the long-term follow-up: a consecutive SEP study

Clin Neurophysiol. 2011 Aug;122(8):1617-21. doi: 10.1016/j.clinph.2011.01.039. Epub 2011 Feb 25.

Abstract

Objective: To delineate long-term change of cortical excitability by measuring somatosensory evoked potentials (SEPs) in patients with Unverricht-Lundborg disease (ULD).

Methods: SEPs to median nerve stimulation were repeatedly examined in two genetically proven ULD patients manifesting stable condition over 16 years, namely disabling but non-progressive myoclonus and cessation of generalised tonic-clonic seizures.

Results: In both patients, five sets of early cortical components were identified 16 years ago: two tangential components of N20-P20 and P30-N30 and three radial components of P25, N35 and N40. Cortical SEPs were regarded as abnormally enhanced 'giant' based on the N35 amplitude (>mean+3 SD of normal controls). The bimodal negative peaks of N35 and N40 showed different spatial distribution: N35 maximum in the central area and N40 in the centro-parietal area. At present, N35 remained giant while N40 disappeared in both patients.

Conclusions: It is possible that currently preserved giant SEPs at least at N35 reflect disabling cortical myoclonus and that disappearance of N40 might reflect a lesser degree of increased cortico-cortical connectivity and/or decreased cortical hyperexcitability in the association cortices. It might possibly have resulted in the disappearance of GTCSs.

Significance: We delineated long-term change of giant SEP in ULD.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cerebral Cortex / physiopathology*
  • Cystatin B / genetics
  • Electric Stimulation / methods
  • Electroencephalography
  • Evoked Potentials, Somatosensory / physiology*
  • Humans
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Median Nerve / physiopathology
  • Middle Aged
  • Reaction Time / physiology
  • Unverricht-Lundborg Syndrome / genetics
  • Unverricht-Lundborg Syndrome / pathology*
  • Unverricht-Lundborg Syndrome / physiopathology

Substances

  • Cystatin B